Company intelligence / Profile preview

AltheaDx

San Diego, California, United Statesncbi.nlm.nih.gov ↗
Ownership
Private
Employees
~51
Development stage
Commercial
01

Overview

AltheaDx specializes in commercial-stage molecular diagnostic tests focused on pharmacogenomics. Its flagship product, IDgenetix®, provides genetic insights to guide medication selection for depression, anxiety, cardiovascular disease, pain management, and neuropsychiatric disorders. A published randomized controlled trial demonstrated that using IDgenetix prior to prescribing improved outcomes over standard of care. The test has received Medicare reimbursement since late 2020. The company maintains CAP-accredited/CLIA-certified labs in San Diego and was acquired by Castle Biosciences in April 2022.

Therapeutic areas
PsychiatryCardiovascularNeurology
Modalities
Diagnostic test (molecular diagnostics)PCR-based assay (quantitative PCR)Next-generation sequencingMicroarray-based assay
Industry
Molecular Diagnostics
02

Drug pipeline

1 asset

IDgenetix

Commercial
Indications
Major depressive disorder, Schizophrenia, Bipolar disorder, Anxiety disorders, Panic disorder, Obsessive-compulsive personality disorder, Post-traumatic stress disorder, Attention deficit hyperactivity disorder
03

Partnerships

Compendia Bioscience (for OncoScore/cancer biomarker panels)pharmaceutical/biotechnology industry partners for clinical trial support services

Beyond the preview

Go deeper on AltheaDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AltheaDx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call